Dosage Form: Sterile injectable liquid Number of vials: 2-vial formulation Preparation: 1:1 v/v mixture of the 2 vial formulation. 0.6mL of vial #1, ImmunoMAPK -RDOTAP added to vial# 2, HPVmix (0.6 mL) Total Administered dose: 2.7 mg of tota l peptide and 3 mg of R -DOTAP Total Injection Volume: 1.0mL (administered as two individual 0.5mL injections) Injection route: Subcutaneous • 0.6 ml will be drawn up from each vial (Vial #1 Immuno MAPK- RDOTAP, Vial #2 HPV mix) and mixed (total = 1.2ml for the PDS0101 admixture ). Two separate 0.5 ml doses will be injected into the participant .